Considerable escape of SARS-CoV-2 Omicron to antibody neutralization
Research
[키워드] antibodies
antibody
Antibody neutralization
approved
AstraZeneca
Belgium
booster
Booster vaccine
characterized
clinically
collected
Complete
country
COVID-19
COVID-19 vaccine
Delta
dominant
dose
ENhance
examined
expected
individual
infected individual
inhibited
Lineage
monoclonal antibody
Mutation
N-terminal domain
neutralization
neutralized
Neutralizing
Neutralizing activity
nine
omicron
Patient
Pfizer
recipient
SARS-CoV-2
sensitivity
serum sample
South
spread to
Symptom
tested
therapeutic
titre
vaccination
Vaccine
variant
viral fitness
virus
[DOI] 10.1038/s41586-021-04389-z [Article Type] Research
[DOI] 10.1038/s41586-021-04389-z [Article Type] Research